P Sandercock Selected Research

P Sandercock Research Topics

18	Stroke (Strokes) 08/2013 - 01/2000
16	Ischemic Stroke 03/2010 - 01/2000
5	Hemorrhage 01/2012 - 01/2000
5	Venous Thrombosis (Deep-Vein Thrombosis) 04/2005 - 01/2000
2	Atrial Fibrillation 01/2002 - 06/2000
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2012
1	Pulmonary Embolism 01/2004
1	Thrombosis (Thrombus) 01/2004
1	Embolism (Embolus) 01/2003
1	Myocardial Infarction 01/2003
1	Craniocerebral Trauma (Head Injury) 11/2002
1	Infarction (Infarctions) 01/2002
1	Hemorrhagic Stroke 06/2000

7	AnticoagulantsIBA 10/2004 - 01/2000
5	Heparin (Liquaemin)FDA LinkGeneric 04/2005 - 01/2000
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2003 - 01/2000
3	Heparinoids (Heparinoid)IBA 04/2005 - 01/2000
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2005 - 01/2000
2	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2010 - 05/2004
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2001 - 01/2000
2	danaparoid (Orgaran)FDA Link 01/2001 - 01/2000
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2012
1	Tranexamic Acid (AMCA)FDA Link 01/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2002
1	lubeluzoleIBA 01/2002
1	Glutamic Acid (Glutamate)FDA Link 01/2002
1	Excitatory Amino AcidsIBA 01/2002
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2002
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2001
1	Indicators and Reagents (Reagents)IBA 10/2000